Literature DB >> 11566354

Characterization of NR13-related human cell death regulator, Boo/Diva, in normal and cancer tissues.

R Lee1, J Chen, C P Matthews, J K McDougall, P E Neiman.   

Abstract

Mouse Boo/Diva is an ovary-specific member of the Bcl-2 family identified through homology with the avian cell death antagonist NR13. We identified a human orthologue of Boo/Diva, which is highly conserved between mouse and human and related to avian NR13. Human Boo/Diva is also expressed in human liver and kidney in addition to the ovary. We found that green fluorescence protein (EGFP)-tagged Boo/Diva was not exclusively localized to mitochondria before the induction of apoptosis. However, EGFP-Boo/Diva translocated to mitochondria in the process of apoptosis induced by vincristine, a microtubule-interfering agent. Overexpression of human Boo/Diva promoted cell death in HeLa and 293 cells. The cell death antagonist Bcl-XL interacts with Boo, but is unable to protect 293 cells from Boo/Diva-induced cell death. Finally, we mapped human Boo/Diva to chromosome 15q21, a locus known to be related to human cervical cancer. Moreover, we found that genomic DNAs of three of 24 human cervical cancer samples display deletions within their Boo/Diva genes. This result suggests a role for human Boo/Diva in the pathogenesis of cervical cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11566354     DOI: 10.1016/s0167-4781(01)00268-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Evidence for crucial electrostatic interactions between Bcl-2 homology domains BH3 and BH4 in the anti-apoptotic Nr-13 protein.

Authors:  Philippe Lalle; Abdel Aouacheria; Agnès Dumont-Miscopein; Martin Jambon; Séverine Venet; Hélène Bobichon; Pierre Colas; Gilbert Deléage; Christophe Geourjon; Germain Gillet
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

2.  Co-treatment of mouse antral follicles with 17β-estradiol interferes with mono-2-ethylhexyl phthalate (MEHP)-induced atresia and altered apoptosis gene expression.

Authors:  Zelieann R Craig; Jeffrey Singh; Rupesh K Gupta; Jodi A Flaws
Journal:  Reprod Toxicol       Date:  2014-01-09       Impact factor: 3.143

3.  An Integrated Bioinformatics and Computational Biology Approach Identifies New BH3-Only Protein Candidates.

Authors:  Robert G Hawley; Yuzhong Chen; Irene Riz; Chen Zeng
Journal:  Open Biol J       Date:  2012-05-04

Review 4.  What can we learn from mice lacking pro-survival BCL-2 proteins to advance BH3 mimetic drugs for cancer therapy?

Authors:  Kerstin Brinkmann; Ashley P Ng; Carolyn A de Graaf; Andreas Strasser
Journal:  Cell Death Differ       Date:  2022-04-06       Impact factor: 12.067

5.  Bcl2l10, a new Tpx2 binding partner, is a master regulator of Aurora kinase A in mouse oocytes.

Authors:  Su-Yeon Lee; Eun-Young Kim; Kyeoung-Hwa Kim; Kyung-Ah Lee
Journal:  Cell Cycle       Date:  2016-10-18       Impact factor: 4.534

6.  Characterization of the anti-apoptotic mechanism of Bcl-B.

Authors:  Dayong Zhai; Ning Ke; Haichao Zhang; Uri Ladror; Mary Joseph; Andreas Eichinger; Adam Godzik; Shi-Chung Ng; John C Reed
Journal:  Biochem J       Date:  2003-11-15       Impact factor: 3.857

7.  Murine ovarian development is not affected by inactivation of the bcl-2 family member diva.

Authors:  Helen R Russell; Youngsoo Lee; Heather L Miller; Jingfeng Zhao; Peter J McKinnon
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

8.  The restricted binding repertoire of Bcl-B leaves Bim as the universal BH3-only prosurvival Bcl-2 protein antagonist.

Authors:  G J P Rautureau; M Yabal; H Yang; D C S Huang; M Kvansakul; M G Hinds
Journal:  Cell Death Dis       Date:  2012-12-13       Impact factor: 8.469

9.  Diva reduces cell death in response to oxidative stress and cytotoxicity.

Authors:  Nicole Suyun Liu; Xiaoli Du; Jia Lu; Bei Ping He
Journal:  PLoS One       Date:  2012-08-15       Impact factor: 3.240

10.  Polyubiquitination and proteasomal turnover controls the anti-apoptotic activity of Bcl-B.

Authors:  B van de Kooij; R W Rooswinkel; F Kok; M Herrebout; E de Vries; M Paauwe; G M C Janssen; P A van Veelen; J Borst
Journal:  Oncogene       Date:  2013-04-08       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.